Shoppers Drugmart and Loblaw Pharmacy banner - Canadian Foundation for Pharmacy
Search
Close this search box.

2017 Innovation Grants total almost $140K

2017 Innovation Grants total almost $140K | Picture of a prescription pad on a table with the words Opioids - At risk patients - The Canadian Foundation For Pharmacy

2017 Innovation Grants total almost $140K

NOVEMBER 2017 – This year’s Innovation Grant winners will tackle high-dose opioid use, and the optimum role of pharmacists in diabetes follow up and urinary tract infection (UTI) management. The Canadian Foundation for Pharmacy awarded a record $137,606 to three Canadian pharmacist researchers, Dr. Feng Chang, Dr. Lori MacCallum and Dr. Ross Tsuyuki, to pursue their studies. “Through this grant, we will be able to work together to test how we can use the patient-pharmacist interaction to improve understanding of opioid dosing and better support communications between pharmacists and prescribers,” says Chang, who is an associate professor at the University of Waterloo’s School of Pharmacy.

Identifying at-risk patients

Given that opioid prescriptions have tripled in Canada since 2000, Dr. Chang and her team hope to prove that intervention by community pharmacies will result in not only more timely identification of opioid issues, but a greater awareness of high-dose opioid use. “We believe patients, pharmacists and physicians or other prescribers working together will yield the best outcomes when it comes to the safe and effective use of opioids,” she says.

Facilitating diabetes follow-ups

Dr. MacCallum will be using her grant to support research into strategies needed to encourage pharmacist routine follow up after an initial medication review in people with diabetes. While approximately half of Ontarians with diabetes have received a MedsCheck for Diabetes during the first four years of the program, only 2.6% of those under 66 years and 4% of those over 66 have received a billed follow-up appointment. “Follow-up is an essential step in delivering quality care and it is important we better understand the barriers and facilitators so we can implement strategies to allow us to better care for our patients,” she says. “This grant will allow us to continue to build on our previous research, which identified an opportunity for improved follow-up by pharmacists.”

Prescribing for UTIs

Dr. Tsuyuki says, along with funding from the New Brunswick Pharmacists Association, the CFP grant will help demonstrate the impact of pharmacist prescribing in patients with UTIs. The fact the study will have two components—with pharmacists who prescribe antibiotics or perform prescription adaptations or substitution—will allow for the assessment of multiple aspects of UTI management by pharmacists. “This is important for both patient care and pharmacy practice,” he says. “I would like to thank the CFP for supporting research on the impact of pharmacists’ advanced scope of practice on patient outcomes.”

Find more on CFP’s Innovation Fund Grant.

Like it? Share it with your colleagues

Facebook
Twitter
LinkedIn

Related Articles

Join Our Newsletter

Get notified when new articles are published, news events are posted, etc.

Make a Million-Dollar Difference

The Canadian Foundation for Pharmacy is dedicated to advancing the profession of pharmacy by funding practical, grassroots research and innovative models of practice. To do this, CFP relies on donations from individuals and corporations.

Changing Face of Pharmacy

Fall 2023

Services Chart

As part of its annual Changing Face of Pharmacy report, the Canadian Foundation for Pharmacy...

COVID-19 Chart

The federal and provincial governments have enacted a wide range of temporary laws, regulations...